UCLA–Veterans Affairs team develops new tool to help guide pancreatic cyst treatment (2010)
[UCLA Newsroom]
Colon cancer screening more effective earlier in day, study finds (2009)
[UCLA Newsroom]
UCLA/VA Develops Tool to Gauge Quality of Life of Hepatitis B Patients (2007)
[UCLA Newsroom]
UCLA Seeks Adults for Study on Drug’s Effectiveness in Relieving Constipation Caused by Pain Medications (2007)
[UCLA Newsroom]
To Avoid Stomach Upset in Arthritis Patients, Drug Combination More Effective, UCLA/VA Study Finds (2006)
[UCLA Newsroom]
UCLA/VA Study Assesses Cost-Effectiveness of Modern Drugs for Hepatitis B (2005)
[UCLA Newsroom]
UCLA Study Assesses Impact of Hepatitis C on Quality of Life (2005)
[UCLA Newsroom]
Study Shows Common Painkillers Combined With Acid-Reducing Drugs More Cost-Effective, Safer for Managing Arthritis in High-Risk Patients (2005)
[UCLA Newsroom]
UCLA/VA Study Shows Popular Arthritis Drugs Not as Cost-Effective as Common Painkillers in Managing Chronic Arthritis in Most Patients (2003)
[UCLA Newsroom]
Article:
Spiegel BMR, Bolus R, Han S, et al. Development and validation of a disease-targeted health-related quality of life instrument in chronic hepatitis B infection: the HBQOL v1.0. Hepatology 2007;46:113-21
[United Press International]
[Medical News Today]
[Science Daily]
[UCLA Daily Bruin]
Article:
Spiegel BMR, Naliboff B, Mayer E, Bolus R, Gralnek I, Shekelle P. The effectiveness of a model physician-patient relationship versus usual care in irritable bowel syndrome: a randomized controlled trial. Gastroenterology 2005;130:A773
[OB/GYN News]
Article:
Spiegel BMR, Gralnek IM, Bolus R, Mayer E, Chang L, Dulai GS, Naliboff B. Is a negative colonoscopy associated with improved health-related quality of life or reassurance in irritable bowel syndrome? Gastrointestinal Endoscopy 2005;62:892-899
[Innovations Report]
Article:
Spiegel BMR, Kanwal F, Naliboff B, Mayer E. The impact of somatization on gastrointestinal health resource use in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2262-73
[Eureka Alert] [Newswise] [Medical News Today]
Article:
Spiegel BMR, Chiou CF, Ofman JJ. Minimizing complications from nonsteroidal anti-inflammatory drugs: the cost-effectiveness of competing strategies in varying risk groups. Arthritis Care and Research 2005;15:185-97
Selection of over 3500 Google Citations:
[Forbes] [Science Daily] [Dr. Koop.Com] [Yahoo News]
Article:
Spiegel BMR, Farid M, Dulai GS, Gralnek IM, Kanwal F. Comparing rates of dyspepsia with coxibs versus NSAID+PPI: A Systematic Review and Meta-Analysis of Clinical Trial Data. Digestive Disease Week 2005
[MSNBC]
Also featured in the Personal Finance section of the Wall Street Journal
Article:
Spiegel BMR, Gralnek IM, Mayer EB, Bolus R, Dulai GS, Chang L, Naliboff B. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Archives of Internal Medicine 2004;164:1773-1780
[NY Times Science Section - 12/7/04] [WebMD] [MSNBC] [Medical News.net]
Article:
Kanwal F, Gralnek IM, Martin P, Dulai GS, Martin P, Spiegel BMR. The cost-effectiveness of competing therapies in the management of chronic infection with hepatitis B virus. Annals of Internal Medicine 2005;142:821-31.
[Medscape] [Medical News Today.Com] [Newswise]
Article:
Spiegel BMR, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. The impact of hepatitis C on health related quality of life: a systematic review of the literature. Hepatology 2005;41:790-800
[Biology News] [Medi Lexicon] [Doctor's Guide] [Medical News]
Article:
Spiegel BMR, Targownik LE, Dulai GS, Gralnek IM. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Annals of Internal Medicine 2003;138:795-806
[Reuter's Press Release] [HealthScout News]
Also featured in Reuter's Science, Yahoo News, Forbes.com, MSNBC.com, Atlanta Journal Constitution, Lincoln Daily News, Excite Health, and Doctor.com, among others
